Indications, usage and dosage of selinesol

Selinexor, also known asSelinexor, is a drug with significant anti-cancer effects, especially for the treatment of malignant tumors. This drug has a unique mechanism of action. It acts as a nuclear export inhibitor and can effectively prevent the growth and spread of cancer cells.

In combination regimens, selinesol is widely used in the treatment of multiple myeloma in combination with bortezomib and dexamethasone. For patients who have received at least one treatment regimen, the recommended medication regimen is: 100 mg of selinesol taken orally on the first day of each week; the dose of bortezomib is calculated based on the patient's body surface area, and is usually recommended as pan>1.3mg/m2, injected subcutaneously on the first day of each week, and discontinued for one week after four consecutive weeks; dexamethasone is taken orally on the first two days of each week, 20mg each time.

Selinesol can also be combined with dexamethasone for the treatment of multiple myeloma. At this time, it is recommended to take 80mg of selinesol and 20mg of dexamethasone orally on the first and third days of each week respectively.

For the treatment of largeBcell lymphoma (rrDLBCL), 60 mg of selinesol taken orally on the first and third days of each week is recommended.

However, it is worth noting that although the above dosage has been demonstrated through scientific research, in actual application, doctors will still make fine adjustments based on the patient's specific condition, physical condition, and tolerance to the drug. During the period of taking selinesol, patients must strictly follow the doctor's instructions and must not change the dosage without authorization. At the same time, you should closely observe your body's reaction. If serious discomfort or side effects occur, you should stop taking the medicine immediately and consult a doctor in time.

As a cutting-edge anti-cancer drug, Selinisol has achieved remarkable results in the treatment of multiple myeloma and lymphoma. However, in order to ensure the safety and effectiveness of treatment, patients must maintain close communication with their doctors during the medication process and adjust the treatment plan in a timely manner in order to achieve the best therapeutic effect.